Keywords: Streptococcus pneumoniae; Pneumonia; PCV-13; Serotypes; Vaccine;
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: IPD; Non-PCV serotypes; PCV-7; PCV-13; Streptococcus pneumoniae; Vaccine;
T-cell-mediated immune response to pneumococcal conjugate vaccine (PCV-13) and tetanus toxoid vaccine in patients with moderate-to-severe psoriasis during tofacitinib treatment
Keywords: immune response; Janus kinase inhibitor; pneumococcal vaccine; T cell; tetanus toxoid; tofacitinib; CI; confidence interval; ELISA; enzyme-linked immunosorbant assay; GMFR; geometric mean fold rise; JAK; Janus kinase; LTE; long-term extension; OPA; opsono
Prevnar-13 vaccine failure in a mouse model for vitamin A deficiency
Keywords: PCV-13; Prevnar 13; VAD; Vitamin A deficiency; CFU; Colony forming units; SCID; Severe combined immunodeficiency; Pneumococcus; Vitamin A deficiency; Antibody neutralization; Protection; Challenge;
Memory B cell response to a PCV-13 booster in 3.5Â year old children primed with either PCV-7 or PCV-13
Keywords: ASC; antibody secreting cells; BCR; B cell receptor; BMEM; memory B cells; GC; germinal centre; LLD; lower limit of detection; MenC; group C meningococcus; OPA; opsonophagocytic activity; PBMCs; peripheral blood mononuclear cells; PBS; phosphate buffered
The potential role of 13-valent pneumococcal conjugate vaccine in preventing respiratory complications in bacteraemic pneumococcal community-acquired pneumonia
Keywords: CAP; community-acquired pneumonia; COPD; chronic obstructive pulmonary disease; CRP; C reactive protein; FEV1/FVC; Forced Expiratory Volume in one second/Forced Vital Capacity; HIV; Human Immunodeficiency Virus; ICU; intensive care unit; IPD; invasive pne
The Health Economic Impact of Universal Infant Vaccination with the 10-Valent Pneumococcal Nontypeable Haemophilus influenzae Protein D Conjugate Vaccine as Compared with 13-Valent Pneumococcal Conjugate Vaccine in Hong Kong
Keywords: cost-effectiveness; Hong Kong; PCV-10; PCV-13; pneumococcal conjugate vaccine; pneumococcal disease;
Sampling methods for the study of pneumococcal carriage: A systematic review
Keywords: STGG; skim milk-trypton-glucose-glycerin; SGG; skim milk-glycerol-glucose; ETA; egg-thioglycolate-antibiotic media; PCR; polymerase chain reaction; WHO; World Health Organisation; PCV-7; 7-valent pneumococcal conjugate vaccine; PCV-13; 13-valent pneumococ
The cost-effectiveness of a 13-valent pneumococcal conjugate vaccination for infants in England
Keywords: Cost-effectiveness; Pneumococcal conjugate vaccine; PCV-13; Burden of disease;
Vaccination anti-pneumococcique : état des lieux et perspectives
Keywords: Vaccin anti-pneumococcique; PPSV-23; PCV-7; PCV-13; Efficacité vaccinale; Vieillir en bonne santé; Sujets âgés; Pneumococcal vaccine; PPSV-23; PCV-7; PCV-13; Vaccine effectiveness; Healthy aging; Elderly;
The potential cost-effectiveness of infant pneumococcal vaccines in Australia
Keywords: 3Â +Â 0; vaccine dose schedule of 3 infant doses without toddler booster dose; 3Â +Â 1; vaccine dose schedule of 3 infant doses and one toddler dose; AIHW; Australian Institute of Health and Welfare; AR-DRG; Australian refined-diagnosis related group; BEA